Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 3521-3527, July 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collard, J. G.
Right arrow Articles by Roos, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collard, J. G.
Right arrow Articles by Roos, E.

Cell Surface Sialic Acid and the Invasive and Metastatic Potential of T-Cell Hybridomas

John G. Collard1, Jack F. Schijven, Annelies Bikker, Geertje La Riviere, Jan G. M. Bolscher and Ed Roos

Division of Cell Biology, The Netherlands Cancer Institute (Antoni van Leeuwenhoekhuis), 121 Plesmanlaan, 1066 CX Amsterdam, The Netherlands

T-cell hybridomas prepared by fusion of non-invasive non-metastatic BW5147 T-lymphoma cells and activated normal T-cells were found to be highly invasive in vitro and highly metastatic in vivo upon tail vein injection. By prolonged culturing and subcloning, non-invasive, non-metastatic hybrids were selected with modal DNA/cell contents close to the diploid value of both fusion partners. Since normal activated T-cells were invasive in vitro in hepatocyte cultures, these data suggest that invasiveness of the hybrids is derived from the parental normal T-cells and is one of the properties responsible for the metastatic potential of these cells.

Analysis of a large panel of T-cell hybrids with fluorescein isothiocyanate conjugated lectins, specific for terminal galactose and/or N-acetylgalactosamine sugar residues, showed an inverse correlation between expression of lectin receptor sites and invasive and metastatic potential of the hybrids. Soybean agglutinin, as well as peanut agglutinin and Ricinus communis agglutinin, reacted strongly with non- or low-invasive hybrids but only weakly with invasive hybrids. The difference in lectin binding between both types of hybrids appeared to be due to masking of receptor sites by sialic acid. Removal of cell surface sialic acid by neuraminidase treatment unmasked the lectin receptor sites of invasive hybrids to the level of the corresponding sites of non- or low-invasive cells. This increase in active lectin binding sites was simultaneously accompanied by a striking decrease of invasiveness to the level of the low-invasive hybrids. Conversely, the blocking of R. communis agglutinin receptors by sialic acid allowed selection of invasive hybrids from segregating cell populations with the toxic lectin R. communis agglutinin.

The results taken together indicate that sialylation of particular cell surface carbohydrate residues on the T-cell hybridomas is associated with the invasive and metastatic potential of these hybrids. The reduction of invasive potential after removal of cell surface sialic acid provides further evidence for a functional role of this sugar residue in invasiveness of the T-cell hybrids.

1 To whom requests for reprints should be addressed.

Received 8/ 6/85. Revised 1/ 2/86. Revised 3/31/86. Accepted 4/ 2/86.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
M. Lee, H.-J. Lee, S. Bae, and Y.-S. Lee
Protein Sialylation by Sialyltransferase Involves Radiation Resistance
Mol. Cancer Res., August 1, 2008; 6(8): 1316 - 1325.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. Chiricolo, N. Malagolini, S. Bonfiglioli, and F. Dall'Olio
Phenotypic changes induced by expression of {beta}-galactoside {alpha}2,6 sialyltransferase I in the human colon cancer cell line SW948
Glycobiology, February 1, 2006; 16(2): 146 - 154.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Kakugawa, T. Wada, K. Yamaguchi, H. Yamanami, K. Ouchi, I. Sato, and T. Miyagi
Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression
PNAS, August 6, 2002; 99(16): 10718 - 10723.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S Sabri, M Soler, C Foa, A Pierres, A Benoliel, and P Bongrand
Glycocalyx modulation is a physiological means of regulating cell adhesion
J. Cell Sci., January 5, 2000; 113(9): 1589 - 1600.
[Abstract] [PDF]


Home page
ScienceHome page
O. T. Keppler, S. Hinderlich, J. Langner, R. Schwartz-Albiez, W. Reutter, and M. Pawlita
UDP-GlcNAc 2-Epimerase: A Regulator of Cell Surface Sialylation
Science, May 21, 1999; 284(5418): 1372 - 1376.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.